Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD)
Saved in:
| Published in: | Journal of Blood Medicine |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552932593500163 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Journal of Blood Medicine |
| description | |
| discipline_display | Hematology |
| discipline_facet | Hematology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:69129 |
| institution | FRELIP |
| journal_source_facet | Journal of Blood Medicine |
| last_indexed | 2026-06-20T21:28:52.253Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD) Hematology General Hematology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Hematology General Hematology |
| subject_facet | Hematology General Hematology |
| title | A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD) |
| title_alt | Un estudio de fase 1/2, abierto, de dosis única, multicéntrico para evaluar la farmacocinética y seguridad del concentrado de proteína C derivada de plasma humano en pacientes japoneses con deficiencia congénita grave de proteína C (SCPCD) Une étude de phase 1/2, ouverte, à dose unique, multicentrique pour évaluer la pharmacocinétique et la sécurité du concentré de protéine C dérivée du plasma humain chez des patients japonais atteints de déficit congénital sévère en protéine C (SCPCD) Um estudo de fase 1/2, aberto, dose única, multicêntrico para avaliar a farmacocinética e segurança do concentrado de proteína C derivada de plasma humano em pacientes japoneses com deficiência congênita grave de proteína C (SCPCD) |
| title_auth | A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD) |
| title_es_txt | Un estudio de fase 1/2, abierto, de dosis única, multicéntrico para evaluar la farmacocinética y seguridad del concentrado de proteína C derivada de plasma humano en pacientes japoneses con deficiencia congénita grave de proteína C (SCPCD) |
| title_fr_txt | Une étude de phase 1/2, ouverte, à dose unique, multicentrique pour évaluer la pharmacocinétique et la sécurité du concentré de protéine C dérivée du plasma humain chez des patients japonais atteints de déficit congénital sévère en protéine C (SCPCD) |
| title_full | A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD) |
| title_fullStr | A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD) |
| title_full_unstemmed | A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD) |
| title_pt_txt | Um estudo de fase 1/2, aberto, dose única, multicêntrico para avaliar a farmacocinética e segurança do concentrado de proteína C derivada de plasma humano em pacientes japoneses com deficiência congênita grave de proteína C (SCPCD) |
| title_short | A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD) |
| title_sort | a phase 1/2, open-label, single-dose, multicenter study to evaluate the pharmacokinetics and safety of human plasma-derived protein c concentrate in japanese patients with severe congenital protein c deficiency (scpcd) |
| topic | Hematology General Hematology |
| url | https://www.dovepress.com/a-phase-12-open-label-single-dose-multicenter-study-to-evaluate-the-ph-peer-reviewed-fulltext-article-JBM |